Europe PMCopen access
Beyond Public Health and Medicine: The Potential Impact of GLP-1s and Other Incretin Mimetic Medications on Greenhouse Gas Emissions
Obesity, Environmental Health, Glucagon-like Peptide 1, Life Cycle Assessment
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 642442
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.